Prescription patterns of long-acting somatostatin analogues

Prescription patterns of long-acting somatostatin analogues

Background: Acromegaly and endocrine tumors are uncommon morbidities that are currently treated with different drugs. Objective: To determine the prescription patterns of somatostatin analogues in patients affiliated with the Health System of Colombia. Methods: Retrospective cohort study of patients...

Full description

Bibliographic Details
Main Authors:	Jorge Enrique Machado-Alba, Manuel Enrique Machado-Duque
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-03-01
Series:	SAGE Open Medicine
Online Access:	https://doi.org/10.1177/2050312117694795

Similar Items

Patterns of Antibiotic Prescription in Colombia: Are There Differences between Capital Cities and Municipalities?
by: Jorge Enrique Machado-Alba, et al.
Published: (2020-07-01)

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
by: Anna Sowa-Staszczak, et al.
Published: (2021-11-01)

Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
by: Callisia N. Clarke, et al.
Published: (2023-12-01)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
by: Manuel Enrique Machado-Duque, et al.
Published: (2021-05-01)

Antiangiogenic effects of somatostatin analogues.
by: García de la Torre, N, et al.
Published: (2002)

Effectiveness of SMS 201-995, a synthetic, long-acting somatostatin analogue, in treatment of quinine-induced hyperinsulinaemia.
by: Phillips, R, et al.
Published: (1986)

Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
by: Alba Sanjuan-Sanjuan, et al.
Published: (2021-09-01)

Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
by: Basma Haris, et al.
Published: (2020-12-01)

Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues
by: Cecilia Follin, et al.
Published: (2016-08-01)

Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors
by: A A Markovich, et al.
Published: (2015-09-01)

The role of somatostatin analogues in the treatment of neuroendocrine tumours.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

Somatostatin analogues for receptor targeted photodynamic therapy.
by: Slávka Kaščáková, et al.
Published: (2014-01-01)

CURRENT VIEWS ON THE TREATMENT OF ACROMEGALY WITH SOMATOSTATIN ANALOGUES
by: I. A. Ilovaiskaya
Published: (2017-12-01)

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
by: Wolin EM, et al.
Published: (2015-09-01)

Lipid-lowering drug prescriptions in a group of Colombian patients
by: Andres Gaviria-Mendoza, et al.
Published: (2019-12-01)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
by: Hirofumi Watanabe, et al.
Published: (2022-02-01)

Long action somatostatin analogues in patients with TSH-secreted pituitary adenomas: treatment experience
by: L. K. Dzeranova, et al.
Published: (2022-02-01)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005)

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
by: Valentina Ambrosini, et al.
Published: (2022-02-01)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
by: Sang Ouk Chin, et al.
Published: (2019-03-01)

Patterns of use of medications used to treat urinary incontinence and potentially inappropriate prescriptions
by: Luis Fernando Valladales-Restrepo, et al.
Published: (2023-06-01)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
by: Ur, E, et al.
Published: (1992)

Effects of Somatostatin Analogues on Glucose Metabolism in Acromegaly: Friend of Foe?
by: Corin Badiu, MD, PhD
Published: (2016-01-01)

Synthetic somatostatin analogues in cures of bleeding from esophageal varices
by: A A Schyogolev, et al.
Published: (2010-09-01)

Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy
by: Michal Barabas, et al.
Published: (2019-03-01)

THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: K. Y. Kanukoev, et al.
Published: (2015-04-01)

Targeted treatment with somatostatin analogues: widening horizons of clinical practice
by: Vyacheslav S. Pronin, et al.
Published: (2022-10-01)

Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
by: Christina Darden, et al.
Published: (2021-09-01)

Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
by: Martin H. Cherk, et al.
Published: (2018-01-01)

Identification of potentially inappropriate cardiovascular prescriptions in the elderly using Beers’ criteria
by: Alejandro Castro-Rodríguez, et al.
Published: (2020-03-01)

Detailed Insight into the Interaction of Bicyclic Somatostatin Analogue with Cu(II) Ions
by: Aleksandra Marciniak, et al.
Published: (2020-11-01)

Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues
by: Qing Bo, et al.
Published: (2022-05-01)

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
by: René M. M. van Aerts, et al.
Published: (2018-10-01)

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.
by: Sebastian Krug, et al.
Published: (2019-01-01)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
by: Cristina Alvarez-Escola, et al.
Published: (2016-11-01)

Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study
by: Adelman DT, et al.
Published: (2012-12-01)

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
by: Ralf S. Eschbach, et al.
Published: (2023-01-01)

Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
by: Ström T, et al.
Published: (2019-10-01)

Analogue gravity and the island prescription
by: Shahrokh Parvizi, et al.
Published: (2023-08-01)